CBCristina Martínez Bueno

Cristina Martínez Bueno

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cristina Martínez Bueno has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    How do women with a history of childhood sexual abuse experience the preconception and perinatal period? A qualitative systematic review

    by Claudia Ramírez-Gil, Anna Selva, Marta Gallego Barrero, Natalia Muñoz Hidalgo, Cristina Martínez-Bueno, Ivan Solà

  • Open Access

    Perceived quality of care of medical abortions in the public health system in Catalonia (Spain)

    by Encarnación López-Gimeno, Gemma Falguera Puig, Cristina Martínez Bueno, Rosa García-Sierra, Ma. Mercedes Vicente-Hernández, Josep Grau Galtés, Rosa M. Cabedo-Ferreiro

    In Spain, induced abortions are covered by the public health system. In the region of Catalonia, under the scope of Primary Care, the Sexual and Reproducti

  • Open Access

    Universal Cytomegalovirus Screening in the First Trimester of Pregnancy: The Multicentre Observational Cohort Study in the Area of Barcelona ( CITEMB Study)

    by María Ángeles Sánchez‐Durán, Juliana Esperalba, Elena Scazzocchio, Irene Fernández‐Torm, Eva Vázquez‐Segura, Olga Gracia‐Salazar, Marta Calveiro‐Hermo, Jordina Munrós‐Feliu, Astrid Francesch‐Campi, Laia Alcoverro‐Bedos, et al.

    Objective: To determine the CMV seroprevalence among pregnant women and assess the rate of primary CMV infections during the first trimester. Design: Prospective multicentre observational cohort study. Setting: Four primary care centres (ASSIRs) and two tertiary hospitals in Barcelona and its metropolitan area. Pupulation or Sample: Pregnant women attending first‐trimester antenatal visits between October 2022 and September 2024. Methods: All participants underwent CMV IgG and IgM serological testing at the first antenatal visit. Women with positive IgM and low or intermediate IgG avidity were diagnosed with primary CMV infection and managed according to local protocols, including treatment with valaciclovir and fetal follow‐up. Main Outcome Measures: CMV screening acceptance rate, seroprevalence, rate of primary infection, fetal infection, and neonatal outcomes up to one year of age. Results: Of 3 677 pregnant women recruited, 3 357 were included in the final analysis. CMV screening acceptance was high. Seroprevalence was 77.7% (95% CI 76.2%–79.1%), and 743 women (22.1%, 95% CI 20.7%–23.6%) were seronegative. Five cases (0.15%, 95% CI 0.05%–0.37%) of primary CMV infection were identified and treated. No fetal infections were detected by amniocentesis. One newborn tested positive for CMV but remained asymptomatic at birth and at 6 months. Women who were seronegative were generally older, of European origin, and had higher education and employment rates. Conclusions: Universal first‐trimester CMV screening is feasible and well accepted in a public healthcare setting. While the rate of primary infection was low, early identification of seronegative women offers opportunities for preventive counselling and targeted follow‐up.


    • 1 March 2023
      • Vol. 97
    Open Access

    Características de las mujeres migradas atendidas por los Servicios de Salud Reproductiva del Institut Català de la Salut

    by Elisabeth Llamas Reinero, Mª Mercedes Vicente-Hernández, Rosa Cabedo Ferreiro, Josep Maria Manresa-Domínguez, Míriam García Acosta, Cristina Martínez Bueno, Diego José Arévalo-Ayala, Jofre Bielsa-Pascual, Gemma Falguera-Puig, Pere Torán-Monserrat

    La feminización de la migración y la necesidad de dar asistencia sanitaria a una población cada vez más diversa, buscando unos datos óptimos de salud, llevó a plantearse esta investigación. El objetivo fue determinar las características (perfil socio-demográfico, antecedentes obstétricos-ginecológicos y el seguimiento) de gestantes migradas con un proceso de embarazo finalizado en 2019 en Cataluña frente a las autóctonas, en centros públicos (ASSIR-ICS). Este estudio descriptivo se basó en los registros de historia clínica informatizada de mujeres en veintiocho centros dependientes del ICS. Se analizaron las variables según la procedencia de las gestantes y se utilizó la prueba de Ji Cuadrado de Pearson al 5% acompañada del residuo estandarizado corregido para compararlas, así como el análisis de la varianza para la comparación de medias también al 5%. Se analizaron 36.315 registros con edad media de 31,1 años. El IMC al inicio de gestación fue de 25,4. El consumo de tabaco fue del 18,1% entre españolas y del 17,3% en el resto de las europeas. El cribado de violencia machista llegó al 4% en latinoamericanas, siendo estadísticamente superior al resto. El riesgo de preeclampsia fue del 23,4% en subsaharianas. La diabetes gestacional fue diagnosticada principalmente entre paquistaníes (18,5%). La prevalencia de Infecciones de Transmisión Sexual (ITS) fue del 8,6% en latinoamericanas, del 5,8% en españolas y del 4,5% en europeas. Las subsaharianas (58,2%) realizaron un control insuficiente de ecografías y un menor porcentaje de visitas con un 49,5%. El seguimiento del embarazo fue insuficiente en el 79,9% del total de las gestantes rurales. Existen diferencias derivadas del origen geográfico de las gestantes que condicionan el acceso a los servicios sanitarios.


  • Open Access

    Self-Reported Menstrual Alterations During the COVID-19 Syndemic in Spain: A Cross-Sectional Study

    by Laura Medina-Perucha, Tomàs López-Jiménez, Anna Sofie Holst, Constanza Jacques-Aviñó, Jordina Munrós-Feliu, Cristina Martínez-Bueno, Carme Valls-Llobet, Diana Pinzón-Sanabria, Mª Mercedes Vicente-Hernández, Anna Berenguera

    Introduction: Available evidence suggests that there might be an association between the stressors experienced during the COVID-19 syndemic and changes in menstrual patterns. The aim of this study was to assess self-reported menstrual alterations during the COVID-19 syndemic among women and people who menstruate aged 18– 55 in Spain. Materials and Methods: A cross-sectional online survey-based study was conducted (March–July 2021). Descriptive statistics were calculated and multivariate logistic regression models were constructed. This study was conducted as part of the “Equity and Menstrual Health in Spain” research project. Results: Among participants (N=17,455), 39.4% reported menstrual alterations since the start of the syndemic. Participants self-reporting long COVID-19 presented higher odds of menstrual alterations (aOR: 1.34, 95% CI, 1.15-1.57). In participants with no history of COVID-19, the risk for self-reported menstrual alterations was significantly higher based on employment situation, among participants experiencing financial issues (eg, financial issues always/many times < 12 months: aOR: 1.68, 95% CI, 1.48– 1.90), poorer self-perceived health (eg, poor: aOR: 2.00, 95% CI, 1.31– 3.07), and those diagnosed with polycystic ovary syndrome (aOR: 1.13, 95% CI, 1.02– 1.26). Among participants with a self-reported COVID-19 diagnosis, factors that significantly increased the odds for menstrual alterations were experiencing financial strains (eg, financial issues always/many times < 12 months: aOR: 1.53, 95% CI, 1.09– 2.14), poorer self-perceived health (eg, poor: aOR: 3.09, 95% CI, 1.01– 9.52). Overall, factors that decreased the odds of reporting menstrual alterations included age > 25, being a carer, not having a gynecological condition and using hormonal contraception. Discussion and conclusions: Findings suggest an impact of the COVID-19 syndemic on menstrual patterns. Social inequities in reporting menstrual alterations were identified. While the risk of reporting menstrual alterations was higher among participants with long COVID-19, evidence is not conclusive. Further research on menstrual health in the context of COVID-19 is needed, also to inform policy and practice.